glp 1 or semaglutide Compounded GLP-1 - & Tirzepatide Semaglutide | GLP-1 RA |

Breastfeeding should be avoided during treatment with tirzepatide or the treatment should be discontinued

The decision to continue or discontinue should be made collaboratively between patient and clinician, weighing benefits against costs, side effects, and individual preferences, in accordance with current NICE guidance and local NHS commissioning arrangements

The full dose titration period takes 16 to 20 weeks for semaglutide and 20 weeks for tirzepatide, meaning maximum weight loss velocity typically begins 4 to 5 months after starting treatment

He explained that RLS is actually not a condition of the legs rather, it is related to brain iron levels